Meridian Bioscience reported $74.45M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Accelerate Diagnostics AXDX:US 16.21M 6.6M
Atrion ATRI:US 32.46M 922K
Becton, Dickinson and BDX:US $ 4106M 253M
Bio Rad Laboratories BIO:US $ 570.88M 14.24M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Meridian Bioscience VIVO:US $ 74.45M 638K
Orasure Technologies OSUR:US $ 83.68M 10.75M
Sientra SIEN:US 37.49M 1.12M
Staar Surgical STAA:US $ 51.09M 531K
Thermo Fisher Scientific TMO:US $ 8969M 28M
Trinity Biotech TRIB:US 28.88M 9.94M